Skip to content
PubMed This is a summary of 75 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 75 referenced papers

Top Authors

Shamima Rahman
Great Ormond Street Hospital
Josef Finsterer
Yahoo (Spain)
Douglass M. Turnbull
Newcastle University
Heidi L. Rehm
Broad Institute
Sue Richards
Oregon Health & Science University
Gráinne S. Gorman
Wellcome Centre for Mitochondrial Research
Marni J. Falk
Children's Hospital of Philadelphia
Robert McFarland
Newcastle upon Tyne Hospitals NHS Foundation Trust
Leonid A. Sazanov
Institute of Science and Technology Austria
Patrick F. Chinnery
Newcastle University

Top Institutions

Ranked by publications Top 10 institutions
03

Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle upon Tyne, United Kingdom

83 papers

References

References (75)
  1. 1

    Leigh syndrome: Resolving the clinical and genetic heterogeneity paves the way for treatment options.

    Gerards M, Sallevelt SC, Smeets HJ

    Molecular genetics and metabolism 2016; (117(3)):300-12.

    PMID: 26725255
  2. 2

    The neuroimaging of Leigh syndrome: case series and review of the literature.

    Bonfante E, Koenig MK, Adejumo RB, et al.

    Pediatric radiology 2016; (46(4)):443-51 doi:10.1007/s00247-015-3523-5.

    PMID: 26739140
  3. 3

    Ndufs4 related Leigh syndrome: A case report and review of the literature.

    Ortigoza-Escobar JD, Oyarzabal A, Montero R, et al.

    Mitochondrion 2016; (28()):73-8.

    PMID: 27079373
  4. 4

    Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease.

    Martikainen MH, Ng YS, Gorman GS, et al.

    JAMA neurology 2016; (73(6)):668-74 doi:10.1001/jamaneurol.2016.0355.

    PMID: 27111573
  5. 5

    Utility of Whole Exome Sequencing for Genetic Diagnosis of Previously Undiagnosed Pediatric Neurology Patients.

    Kuperberg M, Lev D, Blumkin L, et al.

    Journal of child neurology 2016; (31(14)):1534-1539 doi:10.1177/0883073816664836.

    PMID: 27572814
  6. 6

    Schizophrenia-like symptoms in a patient with Leigh syndrome.

    Satogami K, Takahashi S, Kose A, Shinosaki K

    Asian journal of psychiatry 2017; (25()):249-250 doi:10.1016/j.ajp.2016.12.012.

    PMID: 28262162
  7. 7

    Associations of quality of life with health-related characteristics among children with autism.

    Kuhlthau KA, McDonnell E, Coury DL, et al.

    Autism : the international journal of research and practice 2018; (22(7)):804-813 doi:10.1177/1362361317704420.

    PMID: 28691502
  8. 8

    Pediatric mitochondrial diseases and the heart.

    Enns GM

    Current opinion in pediatrics 2017; (29(5)):541-551 doi:10.1097/MOP.0000000000000535.

    PMID: 28719387
  9. 9

    Involvement of Cerebellum in Leigh Syndrome: Case Report and Review of the Literature.

    Chourasia N, Adejumo RB, Patel RP, Koenig MK

    Pediatric neurology 2017; (74()):97-99 doi:10.1016/j.pediatrneurol.2017.05.008.

    PMID: 28739363
  10. 10

    Japanese Leigh syndrome case treated with EPI-743.

    Kouga T, Takagi M, Miyauchi A, et al.

    Brain & development 2018; (40(2)):145-149 doi:10.1016/j.braindev.2017.08.005.

    PMID: 28916229
  11. 11

    Do parents and children agree on rating a child's HRQOL? A systematic review and Meta-analysis of comparisons between children with attention deficit hyperactivity disorder and children with typical development using the PedsQLTM.

    Lee YC, Yang HJ, Lee WT, Teng MJ

    Disability and rehabilitation 2019; (41(3)):265-275 doi:10.1080/09638288.2017.1391338.

    PMID: 29057670
  12. 12

    Anesthetic Management in Mitochondrial Encephalomyopathy: A Case Report.

    Yamamoto T, Miyazawa N, Yamamoto S, Kawahara H

    Anesthesia progress 2017; (64(4)):235-239 doi:10.2344/anpr-64-03-06.

    PMID: 29200367
  13. 13

    Cytochrome C oxydase deficiency: SURF1 gene investigation in patients with Leigh syndrome.

    Maalej M, Kammoun T, Alila-Fersi O, et al.

    Biochemical and biophysical research communications 2018; (497(4)):1043-1048 doi:10.1016/j.bbrc.2018.02.169.

    PMID: 29481804
  14. 14

    Leigh syndrome T8993C mitochondrial DNA mutation: Heteroplasmy and the first clinical presentation in a Vietnamese family.

    Weerasinghe CAL, Bui BT, Vu TT, et al.

    Molecular medicine reports 2018; (17(5)):6919-6925 doi:10.3892/mmr.2018.8670.

    PMID: 29512743
  15. 15

    Novel insights into the functional metabolic impact of an apparent de novo m.8993T>G variant in the MT-ATP6 gene associated with maternally inherited form of Leigh Syndrome.

    Uittenbogaard M, Brantner CA, Fang Z, et al.

    Molecular genetics and metabolism 2018; (124(1)):71-81 doi:10.1016/j.ymgme.2018.03.011.

    PMID: 29602698
  16. 16

    Mutations in SURF1 are important genetic causes of Leigh syndrome in Slovak patients.

    Danis D, Brennerova K, Skopkova M, et al.

    Endocrine regulations 2018; (52(2)):110-118.

    PMID: 29715184
  17. 17

    A Novel NDUFS3 mutation in a Chinese patient with severe Leigh syndrome.

    Lou X, Shi H, Wen S, et al.

    Journal of human genetics 2018; (63(12)):1269-1272 doi:10.1038/s10038-018-0505-0.

    PMID: 30140060
  18. 18

    [An interpretation of the expert consensus on standards for the management of patients with primary mitochondrial disease from the Mitochondrial Medicine Society].

    Guo Y, Hong SQ, Jiang L

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2018; (20(11)):887-892.

    PMID: 30477617
  19. 19

    Fatigue in young people with Duchenne muscular dystrophy.

    El-Aloul B, Speechley KN, Wei Y, et al.

    Developmental medicine and child neurology 2020; (62(2)):245-251 doi:10.1111/dmcn.14248.

    PMID: 30980541
  20. 20

    [Paroxysmal crying and motor regression for more than two months in an infant].

    Wen YX, Wang JP, Chen Y, Bao XH

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(4)):399-404.

    PMID: 31014436
  21. 21

    Health Care for Mitochondrial Disorders in Canada: A Survey of Physicians.

    Paik K, Lines MA, Chakraborty P, et al.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2019; (46(6)):717-726 doi:10.1017/cjn.2019.240.

    PMID: 31387656
  22. 22

    Mortality of Japanese patients with Leigh syndrome: Effects of age at onset and genetic diagnosis.

    Ogawa E, Fushimi T, Ogawa-Tominaga M, et al.

    Journal of inherited metabolic disease 2020; (43(4)):819-826 doi:10.1002/jimd.12218.

    PMID: 31967322
  23. 23

    A meta-analysis and systematic review of Leigh syndrome: clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations.

    Chang X, Wu Y, Zhou J, et al.

    Medicine 2020; (99(5)):e18634 doi:10.1097/MD.0000000000018634.

    PMID: 32000367
  24. 24

    Pathogenic variants in SQOR encoding sulfide:quinone oxidoreductase are a potentially treatable cause of Leigh disease.

    Friederich MW, Elias AF, Kuster A, et al.

    Journal of inherited metabolic disease 2020; (43(5)):1024-1036 doi:10.1002/jimd.12232.

    PMID: 32160317
  25. 25

    Clinical Characteristics of Early-Onset and Late-Onset Leigh Syndrome.

    Hong CM, Na JH, Park S, Lee YM

    Frontiers in neurology 2020; (11()):267 doi:10.3389/fneur.2020.00267.

    PMID: 32351444
  26. 26

    Cerebellar stroke-like lesions in Leigh syndrome may mimic cerebellar cortical bleeding.

    Finsterer J

    eNeurologicalSci 2020; (19()):100234 doi:10.1016/j.ensci.2020.100234.

    PMID: 32518845
  27. 27

    Fatal cerebellar oedema in adult Leigh syndrome.

    Edwards LS, Halmagyi GM, Mallawaarachchi A, et al.

    Practical neurology 2020; (20(4)):336-337 doi:10.1136/practneurol-2019-002409.

    PMID: 32680832
  28. 28

    Novel LRPPRC compound heterozygous mutation in a child with early-onset Leigh syndrome French-Canadian type: case report of an Italian patient.

    Piro E, Serra G, Antona V, et al.

    Italian journal of pediatrics 2020; (46(1)):140 doi:10.1186/s13052-020-00903-7.

    PMID: 32972427
  29. 29

    Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines.

    Barcelos I, Shadiack E, Ganetzky RD, Falk MJ

    Current opinion in pediatrics 2020; (32(6)):707-718 doi:10.1097/MOP.0000000000000954.

    PMID: 33105273
  30. 30

    Complex I deficiency and Leigh syndrome through the eyes of a clinician.

    Reinson K, Õunap K

    EMBO molecular medicine 2020; (12(11)):e13187 doi:10.15252/emmm.202013187.

    PMID: 33124751
  31. 31

    Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection.

    Sen K, Harrar D, Hahn A, et al.

    Journal of neurology 2021; (268(11)):3988-3991 doi:10.1007/s00415-021-10538-1.

    PMID: 33796896
  32. 32

    Ptosis, ophthalmoplegia and corneal endothelial disease - ocular manifestations of mitochondrial disease.

    McElnea EM, Pick ZS, Smyth AC, et al.

    American journal of ophthalmology case reports 2021; (22()):101073 doi:10.1016/j.ajoc.2021.101073.

    PMID: 33869891
  33. 33

    Homoplasmy of the m. 8993 T>G variant in a patient without MRI findings of Leigh syndrome, ataxia or retinal abnormalities.

    Saneto RP, Patrick KE, Perez FA

    Mitochondrion 2021; (59()):58-62 doi:10.1016/j.mito.2021.04.010.

    PMID: 33894360
  34. 34

    Leigh Syndrome and SURF1 Gene Presenting with Febrile Seizure.

    Panda PK, Sharawat IK, Sharma V, Sherwani P

    Annals of Indian Academy of Neurology 2021; (24(2)):251-252 doi:10.4103/aian.AIAN_567_20.

    PMID: 34220073
  35. 35

    Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome.

    Ling Q, Rioux M, Hu Y, et al.

    Molecular therapy. Methods & clinical development 2021; (23()):158-168 doi:10.1016/j.omtm.2021.09.001.

    PMID: 34703839
  36. 36

    Leigh syndrome in an infant: autopsy and histopathology findings.

    Saini AG, Chatterjee D, Bhagwat C, et al.

    Autopsy & case reports 2021; (11()):e2021334 doi:10.4322/acr.2021.334.

    PMID: 34805005
  37. 37

    Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.

    van de Wal MAE, Adjobo-Hermans MJW, Keijer J, et al.

    Brain : a journal of neurology 2022; (145(1)):45-63 doi:10.1093/brain/awab426.

    PMID: 34849584
  38. 38

    Differential effects of mTOR inhibition and dietary ketosis in a mouse model of subacute necrotizing encephalomyelopathy.

    Bornstein R, James K, Stokes J, et al.

    Neurobiology of disease 2022; (163()):105594 doi:10.1016/j.nbd.2021.105594.

    PMID: 34933094
  39. 39

    Development of Leigh syndrome with a high probability of cardiac manifestations in infantile-onset patients with m.14453G > A.

    Shimura M, Onuki T, Sugiyama Y, et al.

    Mitochondrion 2022; (63()):1-8 doi:10.1016/j.mito.2021.12.005.

    PMID: 34933128
  40. 40

    Expression signature of the Leigh syndrome French-Canadian type.

    Bchetnia M, Tardif J, Morin C, Laprise C

    Molecular genetics and metabolism reports 2022; (30()):100847 doi:10.1016/j.ymgmr.2022.100847.

    PMID: 35242578
  41. 41

    Novel NARS2 variant causing leigh syndrome with normal lactate levels.

    Tanaka R, Takeguchi R, Kuroda M, et al.

    Human genome variation 2022; (9(1)):12 doi:10.1038/s41439-022-00191-z.

    PMID: 35508527
  42. 42

    Biotin-Responsive Basal Ganglia Disease: Treatable Metabolic Disorder with SLC19A3 Mutation Presenting as Rapidly Progressive Dementia.

    Oommen AT, Polavarapu K, Christopher R, Netravathi M

    Neurology India 2022; (70(2)):733-736 doi:10.4103/0028-3886.344659.

    PMID: 35532649
  43. 43

    Endocrine Manifestations and New Developments in Mitochondrial Disease.

    Ng YS, Lim AZ, Panagiotou G, et al.

    Endocrine reviews 2022; (43(3)):583-609 doi:10.1210/endrev/bnab036.

    PMID: 35552684
  44. 44

    Screening and prevalence of cardiac abnormalities on electro- and echocardiography in a large cohort of patients with mitochondrial disease.

    Hendrix CLF, van den Heuvel FMA, Rodwell L, et al.

    Molecular genetics and metabolism 2022; (136(3)):219-225 doi:10.1016/j.ymgme.2022.05.004.

    PMID: 35659503
  45. 45

    AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives.

    Hanaford AR, Cho YJ, Nakai H

    Orphanet journal of rare diseases 2022; (17(1)):217 doi:10.1186/s13023-022-02324-7.

    PMID: 35668433
  46. 46

    Heteroplasmic Mutant Load Differences in Mitochondrial DNA-Associated Leigh Syndrome.

    Na JH, Lee YM

    Pediatric neurology 2023; (138()):27-32 doi:10.1016/j.pediatrneurol.2022.09.006.

    PMID: 36335839
  47. 47

    Home Milrinone in Pediatric Hospice Care of Children with Heart Failure.

    Hollander SA, Wujcik K, Schmidt J, et al.

    Journal of pain and symptom management 2023; (65(3)):216-221 doi:10.1016/j.jpainsymman.2022.11.014.

    PMID: 36417945
  48. 48

    Transcriptomic analyses reveal neuronal specificity of Leigh syndrome associated genes.

    Wahedi A, Soondram C, Murphy AE, et al.

    Journal of inherited metabolic disease 2023; (46(2)):243-260 doi:10.1002/jimd.12578.

    PMID: 36502462
  49. 49

    Generation of two mother-child pairs of iPSCs from maternally inherited Leigh syndrome patients with m.8993 T > G and m.9176 T > G MT-ATP6 mutations.

    Henke MT, Zink A, Diecke S, et al.

    Stem cell research 2023; (67()):103030 doi:10.1016/j.scr.2023.103030.

    PMID: 36669241
  50. 50

    Leigh syndrome.

    Rahman S

    Handbook of clinical neurology 2023; (194()):43-63 doi:10.1016/B978-0-12-821751-1.00015-4.

    PMID: 36813320
  51. 51

    Case report: malignant hypertension associated with catecholamine excess in a patient with Leigh syndrome.

    Solis A, Shimony J, Shinawi M, Barton KT

    Clinical hypertension 2023; (29(1)):7 doi:10.1186/s40885-022-00231-4.

    PMID: 36855210
  52. 52

    Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations.

    Chung CCY, Hue SPY, Ng NYT, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2023; (25(9)):100896 doi:10.1016/j.gim.2023.100896.

    PMID: 37191093
  53. 53

    Leigh syndrome global patient registry: uniting patients and researchers worldwide.

    Zilber S, Woleben K, Johnson SC, et al.

    Orphanet journal of rare diseases 2023; (18(1)):264 doi:10.1186/s13023-023-02886-0.

    PMID: 37667390
  54. 54

    Schizophrenia-Like Psychotic Symptoms Associated to Leigh Syndrome.

    Jaballah F, Ben Soussia Nouira R, Mallouli S, et al.

    Case reports in psychiatry 2023; (2023()):8886555 doi:10.1155/2023/8886555.

    PMID: 37693747
  55. 55

    Comparison of first-tier whole-exome sequencing with a multi-step traditional approach for diagnosing paediatric outpatients: An Italian prospective study.

    Rosina E, Pezzani L, Apuril E, et al.

    Molecular genetics & genomic medicine 2024; (12(1)):e2316 doi:10.1002/mgg3.2316.

    PMID: 38041506
  56. 56

    A novel mitochondrial DNA variant in MT-ND6: m.14430A>C p.(Trp82Gly) identified in a patient with Leigh syndrome and complex I deficiency.

    Meldau S, Ackermann S, Riordan G, et al.

    Molecular genetics and metabolism reports 2024; (39()):101078 doi:10.1016/j.ymgmr.2024.101078.

    PMID: 38571879
  57. 57

    NDUFV1-Related Mitochondrial Complex-1 Disorders: A Retrospective Case Series and Literature Review.

    Mahesan A, Choudhary PK, Kamila G, et al.

    Pediatric neurology 2024; (155()):91-103 doi:10.1016/j.pediatrneurol.2024.02.012.

    PMID: 38626668
  58. 58

    Late-Onset Leigh Syndrome With Protracted Gastrointestinal Manifestations: A Rare Case Report.

    Amar Z, Hussaini H, Kachhadia MP, et al.

    Cureus 2024; (16(5)):e59669 doi:10.7759/cureus.59669.

    PMID: 38836159
  59. 59

    Exclusion of sulfide:quinone oxidoreductase from mitochondria causes Leigh-like disease in mice by impairing sulfide metabolism.

    Kanemaru E, Shimoda K, Marutani E, et al.

    The Journal of clinical investigation 2024; (134(15)).

    PMID: 38870029
  60. 60

    Evaluating the efficacy of vatiquinone in preclinical models of mitochondrial disease.

    Kayser EB, Chen Y, Mulholland M, et al.

    Research square 2024; doi:10.21203/rs.3.rs-4202689/v1.

    PMID: 38883711
  61. 61

    Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome.

    Nakai R, Varnum S, Field RL, et al.

    Nature metabolism 2024; (6(10)):1886-1896 doi:10.1038/s42255-024-01125-5.

    PMID: 39223312
  62. 62

    [Leigh syndrome caused by the mitochondrial m.8993T>G mutation with hypocitrullinemia: a report of four cases and literature review].

    Li YX, Wang DJ, Zhou MB, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2024; (26(9)):940-945 doi:10.7499/j.issn.1008-8830.2404036.

    PMID: 39267509
  63. 63

    Genetic analysis of 280 children with unexplained developmental delay or intellectual disability using whole exome sequencing.

    Xu J, Su W, Wang Y, et al.

    BMC pediatrics 2024; (24(1)):766 doi:10.1186/s12887-024-05245-5.

    PMID: 39587513
  64. 64

    Biallelic variants in the NDUFAF6 cause mitochondrial respiratory complex assembly defects associated with Leigh syndrome in probands.

    Zhou Y, Zeng X, Zhang L, et al.

    Molecular genetics and metabolism reports 2024; (41()):101168 doi:10.1016/j.ymgmr.2024.101168.

    PMID: 39720739
  65. 65

    Novel intronic variant in NDUFS7 gene results in mitochondrial complex I assembly defect with early basal ganglia and midbrain involvement with progressive neuroimaging findings.

    Oikarainen J, Hinttala R, Nayebzadeh N, et al.

    Mitochondrion 2025; (81()):102007 doi:10.1016/j.mito.2025.102007.

    PMID: 39894241
  66. 66

    Clinical spectrum, treatment and outcomes of the m.10197G>A mutation in MT-ND3: a case report, systematic review and meta-analysis.

    Shi Y, Chen B, Niu S, et al.

    Orphanet journal of rare diseases 2025; (20(1)):59 doi:10.1186/s13023-025-03588-5.

    PMID: 39923090
  67. 67

    The genotype/phenotype conundrum of inherited mitochondrial disorders: Insights from a survey of mtDNA mutations associated with Leigh syndrome in complex I.

    Ahmadi ZA, Brandt U

    Biochimica et biophysica acta. Molecular basis of disease 2025; (1871(8)):167996 doi:10.1016/j.bbadis.2025.167996.

    PMID: 40716504
  68. 68

    Deep Brain Stimulation in Leigh-Like Syndrome Due to DNM1 Pathogenic Variant.

    Villa-Villegas L, Lira-Jaime LG, Farías-Moreno KC, et al.

    Tremor and other hyperkinetic movements (New York, N.Y.) 2025; (15()):32 doi:10.5334/tohm.1017.

    PMID: 40717768
  69. 69

    Identification of novel NDUFA3 variants in a patient with mitochondrial disorders.

    Sun Y, Wei X, Xiao B, et al.

    Pediatric research 2026; (99(5)):1970-1979 doi:10.1038/s41390-025-04403-4.

    PMID: 41038977
  70. 70

    Biallelic NDUFA9 variants cause a progressive neurodevelopmental disorder with prominent dystonia and mitochondrial complex I deficiency.

    Magrinelli F, Taylor LS, Sedighzadeh S, et al.

    Brain communications 2025; (7(5)):fcaf369 doi:10.1093/braincomms/fcaf369.

    PMID: 41069424
  71. 71

    Mitochondrial Leigh syndrome: the state of the art.

    Toutain G, Hoebeke C, Gastaldi M, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2025; (32(8)):509-516 doi:10.1016/j.arcped.2025.04.007.

    PMID: 41193338
  72. 72

    From Congenital Torticollis to Leigh Syndrome: A Case Report of Diagnostic Evolution in an Infant.

    Jeon M, Yang SS, Lee S, Choi JY

    Children (Basel, Switzerland) 2025; (12(11)) doi:10.3390/children12111522.

    PMID: 41300639
  73. 73

    Clinical insights into mitochondrial retinopathy: A case report on m.3243A>G mutation and macular dystrophy.

    Othmani NB, Mathew S

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2025; (39(4)):416-418 doi:10.4103/sjopt.sjopt_314_24.

    PMID: 41367844
  74. 74

    Comprehensive Iranian guidelines for the diagnosis and management of mitochondrial disorders: an evidence- and consensus-based approach.

    Dalili S, Rostampour N, Mousavi ST, et al.

    Orphanet journal of rare diseases 2025; (20(1)):623 doi:10.1186/s13023-025-04127-y.

    PMID: 41420182
  75. 75

    Leigh Syndrome Pathomechanism Involves Region-Specific Innate Immune Activation in Ndufs4 Knockout Mice.

    Fouché BR, Khumalo SG, Koopman WJH, Venter M

    Cellular and molecular neurobiology 2026; (46(1)):42 doi:10.1007/s10571-026-01681-2.

    PMID: 41636927